DSM to restructure pharma units in line with its 'Vision 2010'

摘要

US-based DSM Pharmaceutical Products is set to restructure the activities of its business units DSM Pharma Chemicals and DSM Biologies.The restructuring follows a study (forming part of DSM's recently introduced strategy Vision 2010) involving a closer scrutiny of DSM's pharma assets.